Cargando…

Patients' knowledge and concerns about using the implantable cardioverter defibrillator for the primary prevention of sudden cardiac death and its correlates: A cross‐sectional study

BACKGROUND AND AIMS: Sudden cardiac death (SCD) is one of the most common causes of mortality in heart failure (HF) patients with reduced ejection fraction. Patients have concerns about the disease and use the implantable cardioverter defibrillator (ICD) to reduce the effects of HF disease. The curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zakeri, Mohammad A., Sedri, Nadia, Bazmandegan, Golamreza, Zakeri, Maryam, Safariyan, Mohammad, Dehghan, Mahlagha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193961/
https://www.ncbi.nlm.nih.gov/pubmed/35734342
http://dx.doi.org/10.1002/hsr2.698
_version_ 1784726599227146240
author Zakeri, Mohammad A.
Sedri, Nadia
Bazmandegan, Golamreza
Zakeri, Maryam
Safariyan, Mohammad
Dehghan, Mahlagha
author_facet Zakeri, Mohammad A.
Sedri, Nadia
Bazmandegan, Golamreza
Zakeri, Maryam
Safariyan, Mohammad
Dehghan, Mahlagha
author_sort Zakeri, Mohammad A.
collection PubMed
description BACKGROUND AND AIMS: Sudden cardiac death (SCD) is one of the most common causes of mortality in heart failure (HF) patients with reduced ejection fraction. Patients have concerns about the disease and use the implantable cardioverter defibrillator (ICD) to reduce the effects of HF disease. The current study aims to evaluate the barriers and factors affecting the implantation of the ICD for primary prevention. METHODS: One hundred‐forty‐seven patients with HF were studied in public hospitals in southern Iran by using a cross‐sectional design from April 2018 to June 2019. Demographic, researcher‐made questionnaire, World Health Organization Quality of life‐BREF (WHOQOL‐BREF), general self‐efficacy questionnaires, and Multidimensional Scale of Perceived Social Support (MSPSS) were measured for investigating the barriers and impact factors in patent HF. RESULTS: Most participants were male (56.5%), married (88.4%), illiterate (54.1%), and unemployed (72.6%). 62.6% (n = 92) of the participants did not know about HF and ICD. The total score of patients' concerns about using ICD was 47.11 ± 11.26, which showed a moderate level. The scores of knowledge about HF and ICD had a significant positive poor correlation with self‐efficacy, perceived social support and QoL. Also, the score of concerns about the ICD had a significant negative poor correlation with perceived social support. CONCLUSION: Understanding HF patients' issues and obstacles can help us prevent sudden death. Doctors' advice has a significant impact on patients' acceptance. Poor knowledge is the most important reason for nonparticipation. Intervention is necessary to inform patients to understand the advantages and disadvantages.
format Online
Article
Text
id pubmed-9193961
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91939612022-06-21 Patients' knowledge and concerns about using the implantable cardioverter defibrillator for the primary prevention of sudden cardiac death and its correlates: A cross‐sectional study Zakeri, Mohammad A. Sedri, Nadia Bazmandegan, Golamreza Zakeri, Maryam Safariyan, Mohammad Dehghan, Mahlagha Health Sci Rep Original Research BACKGROUND AND AIMS: Sudden cardiac death (SCD) is one of the most common causes of mortality in heart failure (HF) patients with reduced ejection fraction. Patients have concerns about the disease and use the implantable cardioverter defibrillator (ICD) to reduce the effects of HF disease. The current study aims to evaluate the barriers and factors affecting the implantation of the ICD for primary prevention. METHODS: One hundred‐forty‐seven patients with HF were studied in public hospitals in southern Iran by using a cross‐sectional design from April 2018 to June 2019. Demographic, researcher‐made questionnaire, World Health Organization Quality of life‐BREF (WHOQOL‐BREF), general self‐efficacy questionnaires, and Multidimensional Scale of Perceived Social Support (MSPSS) were measured for investigating the barriers and impact factors in patent HF. RESULTS: Most participants were male (56.5%), married (88.4%), illiterate (54.1%), and unemployed (72.6%). 62.6% (n = 92) of the participants did not know about HF and ICD. The total score of patients' concerns about using ICD was 47.11 ± 11.26, which showed a moderate level. The scores of knowledge about HF and ICD had a significant positive poor correlation with self‐efficacy, perceived social support and QoL. Also, the score of concerns about the ICD had a significant negative poor correlation with perceived social support. CONCLUSION: Understanding HF patients' issues and obstacles can help us prevent sudden death. Doctors' advice has a significant impact on patients' acceptance. Poor knowledge is the most important reason for nonparticipation. Intervention is necessary to inform patients to understand the advantages and disadvantages. John Wiley and Sons Inc. 2022-06-13 /pmc/articles/PMC9193961/ /pubmed/35734342 http://dx.doi.org/10.1002/hsr2.698 Text en © 2022 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Zakeri, Mohammad A.
Sedri, Nadia
Bazmandegan, Golamreza
Zakeri, Maryam
Safariyan, Mohammad
Dehghan, Mahlagha
Patients' knowledge and concerns about using the implantable cardioverter defibrillator for the primary prevention of sudden cardiac death and its correlates: A cross‐sectional study
title Patients' knowledge and concerns about using the implantable cardioverter defibrillator for the primary prevention of sudden cardiac death and its correlates: A cross‐sectional study
title_full Patients' knowledge and concerns about using the implantable cardioverter defibrillator for the primary prevention of sudden cardiac death and its correlates: A cross‐sectional study
title_fullStr Patients' knowledge and concerns about using the implantable cardioverter defibrillator for the primary prevention of sudden cardiac death and its correlates: A cross‐sectional study
title_full_unstemmed Patients' knowledge and concerns about using the implantable cardioverter defibrillator for the primary prevention of sudden cardiac death and its correlates: A cross‐sectional study
title_short Patients' knowledge and concerns about using the implantable cardioverter defibrillator for the primary prevention of sudden cardiac death and its correlates: A cross‐sectional study
title_sort patients' knowledge and concerns about using the implantable cardioverter defibrillator for the primary prevention of sudden cardiac death and its correlates: a cross‐sectional study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193961/
https://www.ncbi.nlm.nih.gov/pubmed/35734342
http://dx.doi.org/10.1002/hsr2.698
work_keys_str_mv AT zakerimohammada patientsknowledgeandconcernsaboutusingtheimplantablecardioverterdefibrillatorfortheprimarypreventionofsuddencardiacdeathanditscorrelatesacrosssectionalstudy
AT sedrinadia patientsknowledgeandconcernsaboutusingtheimplantablecardioverterdefibrillatorfortheprimarypreventionofsuddencardiacdeathanditscorrelatesacrosssectionalstudy
AT bazmandegangolamreza patientsknowledgeandconcernsaboutusingtheimplantablecardioverterdefibrillatorfortheprimarypreventionofsuddencardiacdeathanditscorrelatesacrosssectionalstudy
AT zakerimaryam patientsknowledgeandconcernsaboutusingtheimplantablecardioverterdefibrillatorfortheprimarypreventionofsuddencardiacdeathanditscorrelatesacrosssectionalstudy
AT safariyanmohammad patientsknowledgeandconcernsaboutusingtheimplantablecardioverterdefibrillatorfortheprimarypreventionofsuddencardiacdeathanditscorrelatesacrosssectionalstudy
AT dehghanmahlagha patientsknowledgeandconcernsaboutusingtheimplantablecardioverterdefibrillatorfortheprimarypreventionofsuddencardiacdeathanditscorrelatesacrosssectionalstudy